Thomson Hospital Kota Damansara Ushers In New Treatment for Spinal Muscular Atrophy
First in SEA to administer US-approved Spinraza for the rare genetic disorder PETALING JAYA, 12 July 2023: Thomson Hospital Kota Damansara (THKD), the flagship hospital of TMC Life Sciences Berhad (TMCLS), today became the first hospital in Southeast Asia to administer Spinraza, a US Food and Drug Administration (FDA)-approved treatment for Spinal Muscular Atrophy (SMA). […]
Thomson Hospital Kota Damansara Ushers In New Treatment for Spinal Muscular Atrophy Read More »